David Cortez
Faculty Member
Last active: 2/4/2016

  1. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Cortez D, Stoica G, Pierce JH, Pendergast AM (1996) Oncogene 13(12): 2589-94
    › Primary publication · 9000132 (PubMed)
  2. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Cortez D, Kadlec L, Pendergast AM (1995) Mol Cell Biol 15(10): 5531-41
    › Primary publication · 7565705 (PubMed) · PMC230804 (PubMed Central)
  3. Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation. Gishizky ML, Cortez D, Pendergast AM (1995) Proc Natl Acad Sci U S A 92(24): 10889-93
    › Primary publication · 7479904 (PubMed) · PMC40536 (PubMed Central)
  4. Characterization of stable high molecular weight mutagenic product(s) of plant-activated m-phenylenediamine. Seo KY, Riley J, Cortez D, Wagner ED, Plewa MJ (1993) Mutat Res 299(2): 111-20
    › Primary publication · 7680425 (PubMed)